A study recently published in the Journal of Clinical Oncology indicates that frequent aspirin use is associated with reduction in ovarian cancer risk. Further, secondary analyses of RCTs observing administration of aspirin for cardiovascular disease prevention "have noted a decreased risk of female reproductive cancers with at least 3 years of aspirin use." While study authors point out that the ovarian cancer individual cases diagnosed in the study populations were not robust enough to draw definitive conclusions, "meta-analyses and pooled analyses of cohort and case-control studies have found that aspirin may reduce ovarian cancer risk by 10%-20%, particularly when used frequently (e.g. daily or almost daily)."
To learn more about this study, click here.
Source mentioned: Hurwitz LM, Townsend MK, Jordan SJ, et al. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. JCO; Published online 22 July 2022. DOI: 10.1200/JCO.21.01900
No comments:
Post a Comment